TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Amortization of Intangibles (2022 - 2023)

Updated

TScan Therapeutics' Amortization of Intangibles came in at $479,000 for Q4 2023, down 8.8% from $525,000 a year earlier.

Analysis

TScan Therapeutics (TCRX) Amortization of Intangibles (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 1.70 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 1.06 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 608.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 479,000.00
Dec 31, 2022 525,000.00
API Access

TScan Therapeutics Amortization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=TCRX&period=max&api_key=YOUR_API_KEY